Benjamin Samuel Levin, MD Anesthesiology - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-0111 |
Matthew Szaro, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-2526 Fax: 207-662-6236 |
Allen J Hayman, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-2526 |
Theodoros G Papalimberis, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-2526 |
Christina Kenny Giblin, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-2526 |
Dr. Brittney Supp, DO Anesthesiology Medicare: Medicare Enrolled Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-482-7800 Fax: 207-482-7898 |
Dr. Keila Mayes Maher, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-2526 |
Gregory Foster, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-0111 |
Danielle Leahy, Anesthesiology - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-482-7800 Fax: 207-482-7898 |
Barbara A Ryan, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-2526 |
News Archive
Radiologists at ProMedica Toledo Hospital Breast Care Center have a new tool to help evaluate breast tissue density on a mammogram. It's called VolparaDensity™, a breast imaging software tool that uses complex physics and software to measure the amount of tissue within a patient's breast.
Adverse childhood experiences and sleep disturbances interfere with immune system regulation, shows research from the University of Eastern Finland.
Researchers have identified a way in which men can develop prostate cancer after contracting trichomoniasis, a curable but often overlooked sexually transmitted disease.
Genentech, Inc., a wholly owned member of the Roche Group, and Biogen Idec announced today the U.S. Food and Drug Administration (FDA) approved Rituxan® (rituximab) in combination with fludarabine and cyclophosphamide (FC) for people with previously untreated and previously treated CD20-positive chronic lymphocytic leukemia (CLL).
Patients with Alzheimer's disease have a higher risk of developing glioblastoma and a lower risk of lung cancer.
› Verified 3 days ago